OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
Vicente Villanueva, Daniel Santos‐Carrasco, Pablo Cabezudo‐García, et al.
Epilepsia Open (2023) Vol. 8, Iss. 3, pp. 918-929
Open Access | Times Cited: 50
Vicente Villanueva, Daniel Santos‐Carrasco, Pablo Cabezudo‐García, et al.
Epilepsia Open (2023) Vol. 8, Iss. 3, pp. 918-929
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
Emilio Perucca, Meir Bialer, H. Steve White
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 755-779
Open Access | Times Cited: 42
Emilio Perucca, Meir Bialer, H. Steve White
CNS Drugs (2023) Vol. 37, Iss. 9, pp. 755-779
Open Access | Times Cited: 42
Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database
Shihao Chen, Wenqiang Fang, Linqian Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Shihao Chen, Wenqiang Fang, Linqian Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
The cenobamate KORK study—A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add‐on lacosamide, perampanel, and brivaracetam
Bernhard J. Steinhoff, Dimitra Georgiou, Tassanai Intravooth
Epilepsia Open (2024) Vol. 9, Iss. 4, pp. 1502-1514
Open Access | Times Cited: 9
Bernhard J. Steinhoff, Dimitra Georgiou, Tassanai Intravooth
Epilepsia Open (2024) Vol. 9, Iss. 4, pp. 1502-1514
Open Access | Times Cited: 9
Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study
Yaroslav Winter, Raya Abou Dargham, Susana Patiño Tobón, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 733-742
Open Access | Times Cited: 9
Yaroslav Winter, Raya Abou Dargham, Susana Patiño Tobón, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 733-742
Open Access | Times Cited: 9
Cenobamate: real-world data from a retrospective multicenter study
Stephan Lauxmann, David Heuer, Jan Heckelmann, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6596-6604
Open Access | Times Cited: 8
Stephan Lauxmann, David Heuer, Jan Heckelmann, et al.
Journal of Neurology (2024) Vol. 271, Iss. 10, pp. 6596-6604
Open Access | Times Cited: 8
Real‐world use of cenobamate in adults: Efficacy and predictors of treatment response
Itai Loushy, Lilach Goldstein, Kathryn N. Devlin, et al.
Epilepsia (2025)
Closed Access | Times Cited: 1
Itai Loushy, Lilach Goldstein, Kathryn N. Devlin, et al.
Epilepsia (2025)
Closed Access | Times Cited: 1
Cenobamate in patients with highly refractory focal epilepsy: A retrospective real-world study
Álvaro Beltrán‐Corbellini, María Romeral‐Jiménez, P. Mayo Rodríguez, et al.
Seizure (2023) Vol. 111, pp. 71-77
Closed Access | Times Cited: 19
Álvaro Beltrán‐Corbellini, María Romeral‐Jiménez, P. Mayo Rodríguez, et al.
Seizure (2023) Vol. 111, pp. 71-77
Closed Access | Times Cited: 19
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program
Roberta Roberti, Giovanni Assenza, Francesca Bisulli, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2909-2922
Open Access | Times Cited: 7
Roberta Roberti, Giovanni Assenza, Francesca Bisulli, et al.
Epilepsia (2024) Vol. 65, Iss. 10, pp. 2909-2922
Open Access | Times Cited: 7
Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug‐resistant focal seizures
Mar Carreño, António Gil‐Nagel, José M. Serratosa, et al.
Epilepsia Open (2024) Vol. 9, Iss. 3, pp. 1051-1058
Open Access | Times Cited: 6
Mar Carreño, António Gil‐Nagel, José M. Serratosa, et al.
Epilepsia Open (2024) Vol. 9, Iss. 3, pp. 1051-1058
Open Access | Times Cited: 6
Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
Bettina Schmitz, Simona Lattanzi, Kristl Vonck, et al.
Epilepsia Open (2023) Vol. 8, Iss. 4, pp. 1241-1255
Open Access | Times Cited: 15
Bettina Schmitz, Simona Lattanzi, Kristl Vonck, et al.
Epilepsia Open (2023) Vol. 8, Iss. 4, pp. 1241-1255
Open Access | Times Cited: 15
Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Medicina (2023) Vol. 59, Iss. 8, pp. 1389-1389
Open Access | Times Cited: 14
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Medicina (2023) Vol. 59, Iss. 8, pp. 1389-1389
Open Access | Times Cited: 14
Add‐on treatment with cenobamate is already effective at low doses in refractory focal epilepsy: A prospective observational study
Yulia Novitskaya, Elisa Schütz, Birgitta Metternich, et al.
Epilepsia (2023) Vol. 65, Iss. 3, pp. 630-640
Open Access | Times Cited: 14
Yulia Novitskaya, Elisa Schütz, Birgitta Metternich, et al.
Epilepsia (2023) Vol. 65, Iss. 3, pp. 630-640
Open Access | Times Cited: 14
Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study
Pedro Jesús Serrano Castro, Teresa Ramirez-García, Pablo Cabezudo‐García, et al.
CNS Drugs (2024) Vol. 38, Iss. 2, pp. 141-151
Open Access | Times Cited: 5
Pedro Jesús Serrano Castro, Teresa Ramirez-García, Pablo Cabezudo‐García, et al.
CNS Drugs (2024) Vol. 38, Iss. 2, pp. 141-151
Open Access | Times Cited: 5
Cenobamate Plasma Levels in Patients with Epilepsy: Correlation with Efficacy and Tolerability?
Bernhard J. Steinhoff, Dimitra Georgiou, Daniel Dietmann, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2757-2757
Open Access | Times Cited: 5
Bernhard J. Steinhoff, Dimitra Georgiou, Daniel Dietmann, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2757-2757
Open Access | Times Cited: 5
Treatment simplification to optimize cenobamate effectiveness and tolerability: A real‐world retrospective study in Spain
J. Rodríguez-Uranga, Juan María Sánchez‐Caro, Roshan Hariramani Ramchandani
Epilepsia Open (2024) Vol. 9, Iss. 4, pp. 1345-1356
Open Access | Times Cited: 5
J. Rodríguez-Uranga, Juan María Sánchez‐Caro, Roshan Hariramani Ramchandani
Epilepsia Open (2024) Vol. 9, Iss. 4, pp. 1345-1356
Open Access | Times Cited: 5
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study
Simona Lattanzi, Federica Ranzato, Carlo Di Bonaventura, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1203-1217
Open Access | Times Cited: 4
Simona Lattanzi, Federica Ranzato, Carlo Di Bonaventura, et al.
Neurology and Therapy (2024) Vol. 13, Iss. 4, pp. 1203-1217
Open Access | Times Cited: 4
Sodium Channel Blockers for the Treatment of Focal Epilepsy: A Chinese Expert Consensus
Rui Yan, Hesheng Zhang, Zhen Hong, et al.
Seizure (2025) Vol. 127, pp. 105-114
Closed Access
Rui Yan, Hesheng Zhang, Zhen Hong, et al.
Seizure (2025) Vol. 127, pp. 105-114
Closed Access
Effectiveness and safety of adjunctive cenobamate in people with focal‐onset epilepsy: Interim results after 24‐week observational period from the BLESS study
Simona Lattanzi, Fedele Dono, G. D’Orsi, et al.
Epilepsia (2025)
Open Access
Simona Lattanzi, Fedele Dono, G. D’Orsi, et al.
Epilepsia (2025)
Open Access
Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medications
Michael R. Sperling, William E. Rosenfeld, John Watson, et al.
Epilepsia (2025) Vol. 66, Iss. S1, pp. 4-14
Open Access
Michael R. Sperling, William E. Rosenfeld, John Watson, et al.
Epilepsia (2025) Vol. 66, Iss. S1, pp. 4-14
Open Access
Real‐world effectiveness and tolerability of cenobamate in drug‐resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP ) in Germany, France, and United Kingdom
Sylvain Rheims, Bernhard J. Steinhoff, Édouard Hirsch, et al.
Epilepsia Open (2025)
Open Access
Sylvain Rheims, Bernhard J. Steinhoff, Édouard Hirsch, et al.
Epilepsia Open (2025)
Open Access
Increase of Brivaracetam serum concentration with introduction of Cenobamate
Lena Bender, Martin Hirsch, Andreas Schulze‐Bonhage
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lena Bender, Martin Hirsch, Andreas Schulze‐Bonhage
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cenobamate as add-on treatment in ultra-refractory focal epilepsy: Real-world results from The Danish Epilepsy Centre, Dianalund, Denmark
Cathrine E. Gjerulfsen, Stefan Juhl, Katarzyna M. Mieszczanek, et al.
Neurological Sciences (2025)
Open Access
Cathrine E. Gjerulfsen, Stefan Juhl, Katarzyna M. Mieszczanek, et al.
Neurological Sciences (2025)
Open Access
